ORBIMED ADVISORS LLC
Q1 2020 13F-HR Holdings
Net value change ($000)
-1,053,974
(-15.0%)
New positions
32
Sold out positions
26
Turnover %
28.8%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ARQT | 139,281 | NEW |
| BIIB | 132,850 | 694.1% |
| PASG | 109,666 | NEW |
| PFE | 98,315 | NEW |
| GILD | 88,789 | 419.0% |
| CNC | 79,354 | NEW |
| SYK | 61,784 | NEW |
| AGIO | 58,638 | NEW |
| IMARA INC | 43,600 | NEW |
| BMRN | 42,738 | 1456.6% |
Top Reduces (Value $000, Stocks/ETFs)
| Synthorx, Inc. | -371,560 | -100.0% |
| Tricida, Inc. | -151,329 | -41.7% |
| ARQULE INC | -99,800 | -100.0% |
| DHR | -98,058 | -100.0% |
| ASND | -94,898 | -20.4% |
| SpringWorks Therapeutics, Inc. | -85,099 | -29.9% |
| INSP | -79,044 | -79.1% |
| REGN | -70,189 | -89.3% |
| EW | -68,110 | -67.1% |
| TNDM | -68,038 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
42,494
(0.7% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|